24 packages found
Problem metabolizing ethanol with ADH (Alcohol dehydrogenase)
Determines lower heart attack risk than average - 10-20% of people
Increased risk of gluten intolerance and celiac disease in europeans
Determines if affected by sickle cell anemia
Problem metabolizing NSAIDs
Your CYP1A2 fast metabolizer status means that you are less stimulated by caffeine.
Most likely CYP2C19 normal, i.e. CYP2C19*1, and therefore of the 'rapid metabolizer' phenotype.
You have a lower risk for developing Parkinson's Disease
You have at least 4 of the 5 genotypes which increase, by approximately 50%, the risk of prostate cancer patients dying of the disease. This does not increase your risk of getting prostate cancer, however.
You are at an increased risk for developing Parkinson's Disease
You have a 6.5x increased risk for breast cancer
Of the 'poor metabolizer' phenotype for CYP2C19.
You have a 1.7x increased risk for panic disorder
You are a CYP2C9 poor metabolizer.
Determine if you have two copies of the ApoE-ε4 allele
- ApoE-ε4 allele
- increased risk
- Alzheimer's disease
- Cardiovascular disease
- Hepatitis C
The 3.7% or so of all individuals who are both rs965513(A;A) and rs944289(T;T) are reported to be at ~5.7x increased risk for thyroid cancer compared to noncarriers
This genoset is to be used with DNA-JSON. See the [dna2json](https://github.com/genomejs/dna2json) repository for more information.
Determines if a genome is 80% likely to be unable to taste bitter. (GS116)
Determines if a genome has an increased risk of Alzheimer's disease. (GS293)
Determines if a genome has an increased risk of baldness (gs122).